Neuronetics Forecasts Q1 FY 2024 Sales Of $16.7M-$17.7M And $78M-$80M For 2024 Versus Consensus Of $16.98M And $78.64M, Respectively
Portfolio Pulse from Benzinga Newsdesk
Neuronetics projects Q1 FY 2024 sales to be between $16.7M-$17.7M and full-year sales to reach $78M-$80M, aligning closely with consensus estimates of $16.98M for Q1 and $78.64M for the year.

March 05, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Neuronetics' sales projections for Q1 FY 2024 and the full year are in line with analyst consensus, indicating stable financial expectations.
The sales forecast by Neuronetics is very close to the consensus estimates, suggesting that the company's financial performance is expected to be stable. This alignment with analyst expectations generally indicates a neutral short-term impact on the stock price, as there are no significant positive or negative surprises.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100